AlphaQuest’s SpringWorks Therapeutics SWTX Stock Holding History

AlphaQuest’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,957	Closed	-$92K	–	2282
2025 Q2	$92K	Sell	1,957 -625	-24%	-$27.8K	0.01%	1460
2025 Q1	$114K	Buy	2,582 +1,578	+157%	+$72.6K	0.01%	1251
2024 Q4	$36.3K	Buy	1,004 +414	+70%	+$14.5K	﹤0.01%	1350
2024 Q3	$18.9K	Sell	590 -1,850	-76%	-$69.1K	﹤0.01%	1510
2024 Q2	$91.9K	Sell	2,440 -2,297	-48%	-$96.7K	0.01%	945
2024 Q1	$233K	Buy	+4,737	New	+$219K	0.04%	602

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaQuest's SWTX Position: Q3 2025 in Review

AlphaQuest sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 1,957 shares — an estimated $92K sold.

AlphaQuest first reported a position in SWTX in Q1 2024 and held it in 6 quarters. The position peaked at $233K in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

AlphaQuest reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
AlphaQuest sold 1,957 SpringWorks Therapeutics shares in Q3 2025, an estimated $92K.
AlphaQuest first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 6 quarters.
AlphaQuest's SpringWorks Therapeutics position peaked at $233K in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on AlphaQuest's 13F filing for Q3 2025, filed 3 Nov 2025.